期刊文献+

非小细胞肺癌患者外周血Th17细胞比例和血清IL-17水平的检测及其临床意义 被引量:6

Detection and clinical significance of Thl7 cell proportion and expression of IL-17 in peripheral bloodof patients with non-small cell lung cancer
原文传递
导出
摘要 目的探讨非小细胞肺癌(NSCLC)患者外周血Th17细胞比例和白细胞介素.17(IL-17)水平的变化及其与患者临床病理的关系。方法收集60例原发未治疗的NSCLC患者(NSCLC组)和20例健康志愿者(对照组),采用流式细胞术(FCM)检测Th17细胞比例,采用酶联免疫吸附试验(ELISA)检测血清IL.17水平。结果NSCLC组Th17细胞占CD;T细胞比例高于对照组[(1.23±0.41)%比(1.05±0.28)%,t=1.679,P=0.097],鳞状细胞癌患者外周血Th17细胞比例明显高于腺癌患者[(1.31±0.39)%比(1.09±0.41)%,t=2.093,P=0.041]。NSCLC组IL-17水平明显高于健康对照组[(21.11±7.87)pg/ml比(17.64±5.07)Pg/ml,t=2.280,P=0.027],鳞状细胞癌患者血清IL-17表达水平明显高于腺癌患者f(23.114-8.73)Pg/ml比(18.54±6.38)Pg/ml,t=2.203,P=0.0321。Th17细胞比例、IL-17的表达水平随临床分期的进展呈下降趋势fF=3.151,P:0.032;F=4.132,P=0.010]。结论NSCLC患者外周血中Th17细胞比例和IL-17的表达与肿瘤病理分型、TNM分期相关,可能在NSCLG.的病程中发挥重要作用。 Objective To investigate the relationship between the proportion of Thl7 cells and IL-17 expression in the peripheral blood and their clinical significance in patients with non-small cell lung cancer (NSCLC). Methods The proportion of Th 17 cells determined by flow cytometry (FCM) and IL-17 detected by enzyme-linked immunosorbent assay (ELISA). The data was analyzed from 60 untreated patients with NSCLC (NSCLC group) and 20 healthy volunteers (control group). Results The Thl7 cells proportion in CD; T-cells in NSCLC group was significantly higher than that in control group [(1.23±0.41) % vs (1.05±0.28) %, t = 1.679, P = 0.097]. The expression levels of Thl7 cells in peripheral blood of patients with squamous cell carcinoma was significantly higher than that in adenoeareinoma patients [(1.31±0.39) % vs (1.09±0.41) %, t = 2.093, P = 0.041]. The concentration of IL-17 of patients with NSCLC was significantly higher than that in control group [(21.11±7.87) pg/m] vs (17.64±5.07) pg/ml, t = 2.280, P = 0.027]. The expression levels of serum IL-17 of squamous cell carcinoma patients was significantly higher than that of adenocarcinoma patients [(23.11± 8.73) pg/ml vs (18.54±6.38) pg/ml, t = 2.203, P = 0.032]. As clinical stage progressed, the proportion of Thl7 cells and IL-17 expression were significantly downtrend IF = 3.151, P = 0.032, F = 4.132, P = 0.010]. Conclusion The levels of Thl7 cells and 1L-17 in the peripheral blood of patients with NSCLC significantly correlated with the pathological types and TNM stage, might play an important role in the course of the disease.
出处 《肿瘤研究与临床》 CAS 2012年第9期600-602,共3页 Cancer Research and Clinic
基金 山西省吕梁市科技攻关项目(st2010143-1)
关键词 b癌 非小细胞肺 流式细胞术 TH17细胞 白细胞介素-17 Carcinoma, non-small cell lung Flow cytometry Th17 cells Interleukin-17
  • 相关文献

参考文献17

  • 1杨海虹,欧阳铭,郜靓,张亚雷.外周血T细胞亚群表达和晚期非小细胞肺癌预后的关系[J].广东医学,2008,29(2):267-268. 被引量:7
  • 2Korn T, Bettelli E, Oukka M, et al. IL-17 and Thl7 cells. Annu RevImmunol, 2009, 27: 485-517.
  • 3Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4T-cell repertoire: the Th17 lineage. Cuit Opin Immunol, 2006,18:349-356.
  • 4Numasaki M, Watanabe M, Suzuki T, et al. IL-17 enhances the netangiogenic activity and in vivo growth of human non small cell lungcancer in SCID mice Through promoting CXCR-2-dependentangiogenesis. J Immunol,2005,175: 6177-6189.
  • 5Chen X,Wan J, Liu J, et al. Increased IL-17-producing cells correlatewith poor survival and lymphangiogenesis in NSCLC patients. LungCancer, 2010,69: 348-354.
  • 6Zhang JP, Yan J, Xu J, et al. Increased intratumoral IL-17 -producingcells correlate with poor survival in hepatocellular carcinoma patients.J Hepatol, 2009, 50: 980-989.
  • 7Muranski P, Boni A, Antony PA, et al. Tumor-specific Th17-polarizedcells eradicate large established melanoma. Blood, 2008, 112: 362-373.
  • 8Dong C. TH17 cells in development: an updated view of theirmolecular identity and genetic programming. Nat Rev Immunol, 2008,8: 337-348.
  • 9Hwang ES. Transcriptional regulation of T helper 17 celldifferentiation. Yonsei Med J, 2010, 51: 484-491.
  • 10Michel ML, Keller AC, Paget C, et al. Identification of an IL-17 -producing NK1. 1 (neg) iNKT cell population involved in airwayneutrophilia. J Exp Med, 2007, 204: 995-1001.

二级参考文献36

共引文献38

同被引文献84

  • 1朱海星,周灵,时国朝,王林林,潘丽娜,万欢英.非小细胞肺癌患者外周血调节性T细胞和辅助性T细胞17的平衡表达特征[J].结核病与肺部健康杂志,2013,2(2). 被引量:1
  • 2MurugaiyanG, SahaB. Protumor vs antitumor functions of IL-17. J Immunol, 2009, 183: 4169-4175.
  • 3Dong C. Th17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol, 2008, 8: 337-348.
  • 4Zhang B, Rang GH, Wet HF, et al. The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophy Res Commun, 2008, 374: 533-537.
  • 5Zhang JP, Yan J, Xu J, et al. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol, 2009, 50: 980-989.
  • 6Shin HCK, Benbernou N, Fekkar H, et al. Regulation of IL-17, IFN-γ, and IL-10 in human CD8^+ T cells by cyclic Amp-dependent signal transduction pathway. Cytokine, 1998, 10: 841-850.
  • 7Huber M, Heink S, Grothe H, et al. A Th17-like developmental process leads to CD8^+ Tc17 cells with reduced cytotoxic activity. Eur J Immunol, 2009, 39: 1716-1725.
  • 8贾文.NSCLC患者外周血Tc17细胞的检测与临床意义.苏州:苏州大学,2011.
  • 9He DG, Li H, Nabiha Y, et al. IL-17 Promotes tumor development through the Induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor Cells. J Immunol, 2010, 184: 2281-2288.
  • 10Nam JS, Terabe M, Kang M J, et al. Transforming growth factor β subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res, 2008, 68: 3915-3923.

引证文献6

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部